About this trial
The aim of the study is to examine the Gyko inertial sensor system in healthy adults. In the study, jump and postural control parameters are assessed with a one-week interval. To evaluate intra-rater reliability, ICC, SEM, and MDC values will be calculated.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
being between the ages of 18 and 35
having no balance issues (such as vertigo) that could affect assessments
having no health problems that would interfere with understanding the assessments.
Disqualifiers
Having known neurological, rheumatological, or musculoskeletal system problems.
Trial population
Sample size calculations were based on the ICC (0.81-0.87) data for jump parameters obtained from the reference study. Accordingly, the minimum acceptable reliability (ICC) (ρ0) was set at 0.70, with the expected reliability (ICC) (ρ1) at 0.85, considering 80% power and a significance level of 0.05. As a result of the power analysis, it was determined that at least 50 participants should be included in the study. Considering a 10% possibility of separation in test-retest for the participants, it was decided to include 55 individuals.
Trial design
Cohort
Cross-sectional
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
The reliability of the jump and postural stability reliability with Gyko inertial system
Assessments will be repeated one week apart to evaluate the reliability of the Gyko inertial system in postural stability and jump performance parameters. Jump and postural stability assessment with Gyko inertial system.
Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options: